Colgate-Palmolive (CL) Stake Decreased by Bush Odonnell Investment Advisors Inc.

Bush Odonnell Investment Advisors Inc. reduced its stake in Colgate-Palmolive (NYSE:CL) by 6.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 96,198 shares of the company’s stock after selling 6,134 shares during the quarter. Colgate-Palmolive makes up approximately 5.9% of Bush Odonnell Investment Advisors Inc.’s investment portfolio, making the stock its 3rd biggest position. Bush Odonnell Investment Advisors Inc.’s holdings in Colgate-Palmolive were worth $7,258,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently made changes to their positions in CL. Renaissance Technologies LLC raised its holdings in Colgate-Palmolive by 42.4% in the 2nd quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock worth $723,020,000 after purchasing an additional 2,903,800 shares during the period. APG Asset Management N.V. raised its holdings in Colgate-Palmolive by 243.0% in the 3rd quarter. APG Asset Management N.V. now owns 4,070,784 shares of the company’s stock worth $296,557,000 after purchasing an additional 2,884,100 shares during the period. Harding Loevner LP raised its holdings in Colgate-Palmolive by 92.0% during the third quarter. Harding Loevner LP now owns 4,742,752 shares of the company’s stock valued at $176,329,000 after acquiring an additional 2,272,675 shares during the period. First Eagle Investment Management LLC raised its holdings in Colgate-Palmolive by 35.8% during the third quarter. First Eagle Investment Management LLC now owns 6,641,548 shares of the company’s stock valued at $483,837,000 after acquiring an additional 1,750,417 shares during the period. Finally, Vanguard Group Inc. raised its holdings in Colgate-Palmolive by 2.4% during the second quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock valued at $5,031,602,000 after acquiring an additional 1,621,392 shares during the period. 72.85% of the stock is currently owned by institutional investors.

A number of equities research analysts have commented on the company. Citigroup raised their price target on Colgate-Palmolive from $75.00 to $80.00 and gave the company a “neutral” rating in a report on Tuesday, January 30th. BNP Paribas cut Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a report on Tuesday, January 30th. Jefferies Group reissued a “hold” rating and set a $79.00 price target on shares of Colgate-Palmolive in a report on Friday, January 26th. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price target on the stock in a report on Tuesday, January 16th. Finally, Macquarie raised Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price target on the stock in a report on Tuesday, December 19th. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and five have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $77.71.

In related news, COO Noel R. Wallace sold 126,304 shares of Colgate-Palmolive stock in a transaction dated Wednesday, January 31st. The stock was sold at an average price of $73.78, for a total value of $9,318,709.12. Following the completion of the transaction, the chief operating officer now owns 305,631 shares in the company, valued at $22,549,455.18. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Vice Chairman Franck J. Moison sold 142,979 shares of Colgate-Palmolive stock in a transaction dated Tuesday, February 6th. The stock was sold at an average price of $70.09, for a total value of $10,021,398.11. Following the completion of the transaction, the insider now owns 224,027 shares of the company’s stock, valued at approximately $15,702,052.43. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 414,019 shares of company stock valued at $29,541,377. Company insiders own 1.02% of the company’s stock.

Colgate-Palmolive (NYSE CL) opened at $69.62 on Thursday. The firm has a market capitalization of $61,730.80, a PE ratio of 30.54, a PEG ratio of 2.60 and a beta of 0.75. The company has a current ratio of 0.47, a quick ratio of 0.34 and a debt-to-equity ratio of 24.42. Colgate-Palmolive has a 12-month low of $67.52 and a 12-month high of $77.91.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 26th. The company reported $0.75 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.75. The firm had revenue of $3.89 billion during the quarter, compared to analyst estimates of $3.92 billion. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.75 earnings per share. sell-side analysts forecast that Colgate-Palmolive will post 3.18 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Stockholders of record on Tuesday, January 23rd will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Monday, January 22nd. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.30%. Colgate-Palmolive’s payout ratio is 70.18%.

COPYRIGHT VIOLATION WARNING: “Colgate-Palmolive (CL) Stake Decreased by Bush Odonnell Investment Advisors Inc.” was first published by Week Herald and is the sole property of of Week Herald. If you are viewing this report on another website, it was stolen and reposted in violation of U.S. and international copyright law. The legal version of this report can be accessed at https://weekherald.com/2018/02/15/colgate-palmolive-cl-stake-decreased-by-bush-odonnell-investment-advisors-inc.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply